Navigation Links
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Date:6/9/2009

SAN CARLOS, Calif., June 9 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the promotion of Lorianne Masuoka, M.D. to the position of Chief Medical Officer. Dr. Masuoka reports to Nektar's Senior Vice President, Drug Development and Chief Drug Development Officer, Randall Moreadith, M.D., Ph.D.

Dr. Masuoka has over 15 years of experience in clinical research and development. As Chief Medical Officer, she will be instrumental in helping to develop Nektar's clinical development strategy while continuing to oversee all clinical development functions, including Clinical Operations, Clinical Pharmacology, Drug Safety, Biometrics and Data Management. Dr. Masuoka joined Nektar in August 2008 as Vice President of Clinical Development.

"Lorianne's extensive clinical experience and superb guidance of our clinical development and operations teams make her an outstanding choice for Chief Medical Officer," said Randall Moreadith, M.D., Ph.D., Senior Vice President, Drug Development and Chief Drug Development Officer of Nektar, "Since joining Nektar, she has been instrumental in building our Drug Development group and assembling an internal Biometrics and Data Management Group, as well as streamlining our clinical operations."

Prior to Nektar, Lorianne was Vice President of Clinical Development at Five Prime Therapeutics where she led the advancement of a number of protein and antibody therapeutics in the areas of oncology, immunology and metabolic disease. Prior to that, Lorianne held senior leadership positions at Chiron and Berlex, where she was instrumental in development of Betaseron(R) for relapsing forms of multiple sclerosis as well as numerous oncology programs.

Dr. Masuoka received her M.D. from the University of California, Davis, completed a Fellowship
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Nektar Therapeutics Reports First Quarter 2009 Financial Results
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
3. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
4. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
5. Nektar Announces Retirement of Irwin Lerner from Board of Directors
6. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
7. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
8. Nektar Therapeutics to Webcast R&D Day on November 12th
9. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
10. Nektar Therapeutics President and CEO Howard W. Robin to Present at Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at UBS 2008 Global Life Sciences Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 ... Almshouse Road, Warrington, Pa. , Details: The Hepatitis ... finding a cure for hepatitis B and improving the quality ... Crystal Ball on Friday, April 11 at Warrington Country Club ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014  RXi Pharmaceuticals ... discovering, developing and commercializing innovative therapies addressing major ... that it received the Notice of Allowance from ... its unique self-delivering RNAi compounds (sd-rxRNA®), for the ...
(Date:1/14/2014)... 14, 2014 During the 1600’s through the ... “The Doctor’s Plague.” In this time period, doctors did not ... at times, to the death of vulnerable patients. In the ... that they may be unwittingly transmitting herpes viruses to their ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ... today that its work entitled "Evaluation of the Safety ... Volunteers" will be presented at the Eleventh Annual Meeting ... San Francisco, California. "The selection of Oramed ...
... 25, 2011 Reportlinker.com announces that a ... its catalogue: Global Automated ... http://www.reportlinker.com/p092467/Global-Automated-And-Rapid-Microbiological-Tests-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic This ... and Rapid Microbiological Tests in US$ Million ...
... some patients develop a potentially deadly blood infection from ... bodies have gene mutations that allow them to stick ... infections because of a biofilm of persistent bacterial bugs ... some strains of the bacteria, Staphylococcus aureus, have just ...
Cached Biology Technology:Oramed Pharmaceuticals Chosen to Present at the Diabetes Technology Meeting (October 27-29, 2011; San Francisco, CA) 2Global Automated And Rapid Microbiological Tests Industry 2Global Automated And Rapid Microbiological Tests Industry 3Global Automated And Rapid Microbiological Tests Industry 4Global Automated And Rapid Microbiological Tests Industry 5Global Automated And Rapid Microbiological Tests Industry 6Global Automated And Rapid Microbiological Tests Industry 7Global Automated And Rapid Microbiological Tests Industry 8Global Automated And Rapid Microbiological Tests Industry 9Global Automated And Rapid Microbiological Tests Industry 10Global Automated And Rapid Microbiological Tests Industry 11Global Automated And Rapid Microbiological Tests Industry 12Global Automated And Rapid Microbiological Tests Industry 13Global Automated And Rapid Microbiological Tests Industry 14Global Automated And Rapid Microbiological Tests Industry 15Global Automated And Rapid Microbiological Tests Industry 16Global Automated And Rapid Microbiological Tests Industry 17Global Automated And Rapid Microbiological Tests Industry 18Global Automated And Rapid Microbiological Tests Industry 19Global Automated And Rapid Microbiological Tests Industry 20Global Automated And Rapid Microbiological Tests Industry 21Global Automated And Rapid Microbiological Tests Industry 22Global Automated And Rapid Microbiological Tests Industry 23Global Automated And Rapid Microbiological Tests Industry 24Global Automated And Rapid Microbiological Tests Industry 25Global Automated And Rapid Microbiological Tests Industry 26Study offers clues as to why some patients get infections from cardiac implants 2Study offers clues as to why some patients get infections from cardiac implants 3Study offers clues as to why some patients get infections from cardiac implants 4Study offers clues as to why some patients get infections from cardiac implants 5
(Date:4/17/2014)... A new modeling study suggests that fish consumption ... infant exposure to long-lived contaminants like persistent organic ... a team of researchers including University of Toronto ... Wania, looks at how different levels of environmental ... behavior of chemicals in the body influenced exposure ...
(Date:4/17/2014)... KAN. A Kansas State University engineer has ... and remotely detects improvised explosive devices. The same ... William Dunn, the Steven M. and Kay L. ... mechanical and nuclear engineering, and his research team ... hidden underground or in car trunks. The distance ...
(Date:4/17/2014)... Several parasites and pathogens that devastate honeybees in Europe, ... Africa, but do not appear to be impacting native ... team of researchers., The invasive pests include including ... East African honeybees appear to be resilient to these ... used to control pests in Europe, Asia and the ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2Patented research remotely detects nitrogen-rich explosives 2East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3
... the controversial method of mining shale gas, is widespread across ... New research in the Annals of the New York ... including pollution from toxic chemicals, the building of well pads ... engendered a great deal of controversy, largely because of its ...
... in India reduce rates of syphilis, HIV and other sexually ... About two million Indians are infected with ... Maharashtra and Tamil Nadu. The study, led by Professor Prabhat ... Health and St. Michael,s Hospital,s Centre for Global Health Research ...
... use to group together and move around the body called ... by scientists at UCL. Published in Nature Cell ... when cancer cells interact with healthy cells in order to migrate ... healthy cells and use them to travel long distances, but how ...
Cached Biology News:HIV prevention among female sex workers in India reduces HIV and syphilis 2'Chase and run' cell movement mechanism explains process of metastasis 2